Abstract
Previous studies showed that women with breast cancer treated in anthroposophic clinic versus conventional care had increased quality of life (QoL) parameters, fighting spirit, and anxiety coping. We have now analyzed immune and QoL factors in these 2 groups for possible differences during the first 6 months after admission, prompted by anthroposophic studies, including mistletoe extracts, showing beneficial immune system effects. Fourteen immunological variables, including leukocyte count, lymphocyte count, activated T cells (CD4+ and CD8+), NK cells, B cells, IL1β, IL6, IL10, and oxytocin, were longitudinally analyzed in both groups (n = 2 × 26). A panel of QoL parameters were analyzed using 3 different instruments. Statistical evaluation included that each patient was its own control. Cytotoxic CD8+ T cell frequency (percent of lymphocytes analyzed by flow-cytometry) significantly decreased over time in the anthroposophic group versus the conventional group (repeated measures ANOVA, p = 0.05). No major differences were observed in other immunological parameters, whereas QoL variables, anxiety decreased and physical symptoms increased/improved significantly in the anthroposophic group (p = 0.04 and p = 0.05, respectively). Ov...Continue Reading
References
Jan 14, 1995·Lancet·R AderD Felten
Mar 3, 1993·Journal of the National Cancer Institute·N K AaronsonJ C de Haes
Apr 1, 1996·Journal of Pediatric Oncology Nursing : Official Journal of the Association of Pediatric Oncology Nurses·K EnskarA Kreuger
Apr 1, 1996·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·M Carlsson, E Hamrin
Oct 19, 2001·Cancer Nursing·M CarlssonE Hamrin
Jul 13, 2002·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Marianne Carlsson, Elisabeth Hamrin
Nov 15, 2003·Cell Death and Differentiation·G Klein
Apr 8, 2004·Acta Oncologica·Marianne CarlssonElisabeth Hamrin
Jul 5, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Marianne CarlssonElisabeth Hamrin
Dec 19, 2006·Evidence-based Complementary and Alternative Medicine : ECAM·Marianne CarlssonElisabeth Hamrin
Mar 6, 2007·Journal of Immunological Methods·Karin Backteman, Jan Ernerudh
May 16, 2007·Journal of Neurology·Tjalf Ziemssen, Simone Kern
Jun 3, 2009·Nature Reviews. Endocrinology·George P Chrousos
Jul 15, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Christopher P FagundesJanice K Kiecolt-Glaser
Dec 23, 2011·International Journal of Cancer. Journal International Du Cancer·I PoschkeR Kiessling
Jan 29, 2013·Hormones and Behavior·Michael J Poulin, E Alison Holman
Sep 21, 2013·Nature Immunology·Thomas F GajewskiYang-Xin Fu
Sep 21, 2013·The Lancet Oncology·Dean OrnishElizabeth H Blackburn
Jan 15, 2014·Breast Care·Jutta Hübner, Volker Hanf
Jan 15, 2014·Global Advances in Health and Medicine : Improving Healthcare Outcomes Worldwide·Gunver S KienleHelmut Kiene
Feb 4, 2014·Current Opinion in Immunology·Jose Luis Perez-GraciaIgnacio Melero
Apr 29, 2014·Geburtshilfe und Frauenheilkunde·F SiedentopfI Kollak
Aug 20, 2014·BioMed Research International·Mohsen MarvibaigiSaravana Kumar Jaganathan
Dec 3, 2014·Psychoneuroendocrinology·Kavita VedharaSteven W Cole
Jan 30, 2015·Frontiers in Psychology·Kerstin Uvnäs-MobergMaria Petersson
Jun 24, 2015·Journal of the National Cancer Institute·Sunita K PatelSmita Bhatia
Sep 24, 2015·Scandinavian Journal of Caring Sciences·Maria Arman, Johanna Hök
Aug 18, 2016·Mitochondrion·Christina BoeckIris-Tatjana Kolassa
Aug 15, 2017·Development and Psychopathology·Christina BoeckIris-Tatjana Kolassa
Sep 8, 2017·Frontiers in Pharmacology·Hashem O AlsaabArun K Iyer
Sep 30, 2017·Frontiers in Human Neuroscience·T Moritz SchladtInga D Neumann